Ac-055-205
Research payments
$458,402
Through program year 2019, $458,402 in research payments was reported against Ac-055-205, across 135 payments, paid by Actelion Pharmaceuticals, Ltd.
- Paid by
- Actelion Pharmaceuticals, Ltd
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2019 | Research | $458,402 | 135 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Jorge Silva Enciso San Diego, CA Named on 9 payments
- Mandar Aras San Francisco, CA Named on 8 payments
- Ronald Zolty Omaha, NE Named on 8 payments
- Melissa Smallfield Richmond, VA Named on 7 payments
- Alexandros Briasoulis Iowa City, IA Named on 6 payments
- Ulrich Jorde New York, NY Named on 6 payments
- Robert Scott Phoenix, AZ Named on 6 payments
- Ravi Dhingra Madison, WI Named on 5 payments
- Brian Houston Charleston, SC Named on 5 payments
- Mark Everley Kansas City, MO Named on 5 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.